Treatment of Cutaneous Larva Migrans with albendazole: preliminary report
Twenty three patients with Cutaneous Larva Migrans syndrome were prospectively treated with 400 mg/day of Albendazole for 3 consecutive days. Clinical response, compliance and tolerance was excellent. Patients were asymptomatic within the first 72 hours of treatment and recurrences did not occurred....
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
1989-02-01
|
Series: | Revista do Instituto de Medicina Tropical de São Paulo |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651989000100012&lng=en&tlng=en |